Geode Capital Management’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.2M Buy
958,565
+43,121
+5% +$198K ﹤0.01% 2897
2026
Q1
$3.45M Buy
915,444
+34,486
+4% +$186K ﹤0.01% 2915
2025
Q4
$6.99M Buy
880,958
+27,802
+3% +$178K ﹤0.01% 2583
2025
Q3
$2.94M Buy
853,156
+7,380
+0.9% +$27.5K ﹤0.01% 3043
2025
Q2
$3.49M Buy
845,776
+43,791
+5% +$146K ﹤0.01% 2911
2025
Q1
$1.93M Buy
801,985
+9,125
+1% +$25.7K ﹤0.01% 3049
2024
Q4
$2.89M Buy
792,860
+8,731
+1% +$39.8K ﹤0.01% 3001
2024
Q3
$4.94M Buy
784,129
+12,709
+2% +$85.5K ﹤0.01% 2764
2024
Q2
$5.15M Buy
771,420
+190,049
+33% +$1.12M ﹤0.01% 2700
2024
Q1
$3.07M Buy
581,371
+16,280
+3% +$76.5K ﹤0.01% 2937
2023
Q4
$2.92M Buy
565,091
+34,793
+7% +$107K ﹤0.01% 2967
2023
Q3
$1.79M Buy
530,298
+43,604
+9% +$286K ﹤0.01% 3107
2023
Q2
$4.03M Buy
486,694
+6,896
+1% +$62.1K ﹤0.01% 2806
2023
Q1
$4.19M Buy
479,798
+12,524
+3% +$139K ﹤0.01% 2717
2022
Q4
$5.71M Buy
467,274
+9,588
+2% +$91.2K ﹤0.01% 2598
2022
Q3
$2.91M Buy
457,686
+138,334
+43% +$1.17M ﹤0.01% 2954
2022
Q2
$2.87M Buy
319,352
+13,536
+4% +$119K ﹤0.01% 2987
2022
Q1
$3.54M Buy
305,816
+112,794
+58% +$1.74M ﹤0.01% 2974
2021
Q4
$3.39M Buy
193,022
+12,796
+7% +$281K ﹤0.01% 3107
2021
Q3
$4.09M Buy
+180,226
New +$5.92M ﹤0.01% 3028

Other funds holding SGHT

Geode Capital Management's SGHT Position: Q2 2026 in Review

Geode Capital Management increased its Sight Sciences (SGHT) stake by 4.7% in Q2 2026, buying an estimated $198K and bringing the position to 958,565 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

Geode Capital Management first reported a position in SGHT in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.99M in Q4 2025. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Geode Capital Management held 958,565 shares of Sight Sciences worth $5.2M as of Q2 2026.
  • Geode Capital Management bought 43,121 Sight Sciences shares in Q2 2026, an estimated $198K.
  • Sight Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2897 holding.
  • Geode Capital Management first reported a position in Sight Sciences in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Sight Sciences position peaked at $6.99M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.